Significantly diminished long-term specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD4 counts and those on antiretroviral therapy

Journal of Acquired Immune Deficiency Syndromes

Volumn 53, Issue 4, 2010, Pages 496-499

  Marinda, Edmore T ^a   Hargrove, John ^b   Preiser, Wolfgang ^b   Slabbert, Hannes ^b   Van Zyl, Gert ^b   Levin, Jonathan ^c   Moulton, Lawrence H ^d   Welte, Alex ^b,e   Humphrey, Jean ^d,f  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c MRC/UVI Uganda Research Unit on AIDS   (Uganda)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^f Zimbabwe Vitamin a for Mother and Babies Project (ZVITAMBO)   (Zambia)

Author keywords

BED; HIV incidence; HIV 1; IgG; Specificity

Indexed keywords

ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CRYOPRESERVATION; DEMOGRAPHY; ENZYME IMMUNOASSAY; FEMALE; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIROTHERAPY; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; DIAGNOSTIC ERRORS; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; VIRAL LOAD; YOUNG ADULT;

EID: 77949389951     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181b61938     Document Type: Article

References (17)

1. Gupta SB, Murphy G, Koenig E, et al. Comparison of methods to detect recent HIV type 1 infection in cross-sectionally collected specimens from a cohort of female sex workers in the Dominican Republic. AIDS Res Hum Retroviruses. 2007;23:1475-1480.
2. Parekh BS, Pau CP, Kennedy MS, et al. Assessment of antibody assays for identifying and distinguishing recent from long-term HIV type 1 infection. AIDS Res Hum Retroviruses. 2001;17:137-146.
3. Janssen RS, Satten GA, Stramer SL, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA. 1998;280:42-48.
4. Parekh BS, Kennedy MS, Dobbs T, et al. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses. 2002;18:295-307.
5. Murphy G, Parry JV. Assays for the detection of recent infections with human immunodeficiency virus type 1. Euro Surveill. 2008;13:4-10.
6. Rawal BD, Degula A, Lebedeva L, et al. Development of a new less-sensitive enzyme immunoassay for detection of early HIV-1 infection. J Acquir Immune Defic Syndr. 2003;33:349-355.
7. Wilson KM, Johnson EI, Croom HA, et al. Incidence immunoassay for distinguishing recent from established HIV-1 infection in therapy-naive populations. AIDS. 2004;18:2253-2259.
8. Constantine NT, Sill AM, Jack N, et al. Improved classification of recent HIV-1 infection by employing a two-stage sensitive/less-sensitive test strategy. J Acquir Immune Defic Syndr. 2003;32:94-103.
9. Parekh BS, McDougal JS. Application of laboratory methods for estimation of HIV-1 incidence. Indian J Med Res. 2005;121:510-518.
10. Sakarovitch C, Rouet F, Murphy G, et al. Do tests devised to detect recent HIV-1 infection provide reliable estimates of incidence in Africa? J Acquir Immune Defic Syndr. 2007;45:115-122.
11. McDougal JS, Parekh BS, Peterson ML, et al. Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay. AIDS Res Hum Retroviruses. 2006;22:945-952.
12. Saphonn V, Parekh BS, Dobbs T, et al. Trends of HIV-1 seroincidence among HIV-1 sentinel surveillance groups in Cambodia, 1999-2002. J Acquir Immune Defic Syndr. 2005;39:587-592.
13. Dobbs T, Kennedy S, Pau CP, et al. Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion. J Clin Microbiol. 2004;42:2623-2628.
14. Hargrove JW, Humphrey JH, Mutasa K, et al. Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay. AIDS. 2008;22: 511-518.
15. Corporation: CB. Calypte HIV-1 BED Incidence EIA. Enzyme Immuno-assay for Population Estimation of HIV-1 Incidence. Portland, OR: Caplypte Biomedical Corporation; 2004.
16. Karita E, Price M, Hunter E, et al. Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa. AIDS. 2007;21:403-408.
17. Barninghausen T, Wallrauch C, Welte A, et al. HIV incidence in rural South Africa: comparison of estimates from longitudinal surveillance and cross-sectional cBED assay testing. PLoS One. 2008;3:e3640.